Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intermittent Androgen Suppression in Localized Prostate Cancer with Biochemical Relapse
NCT00223665Phase 2Completed
- Sponsor
- University of Washington
- Start
- Jan 1997
- Primary completion
- Sep 2012
- Modality
- Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of leuprolide in prostate cancer (PCa), sponsored by University of Washington. Started Jan 1997; status: completed.
02
Drugs
leuprolide
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00223665.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00223665.